whipple
202 articles
If your tumor is in the head of the pancreas and has not spread, you may qualify for a Whipple procedure. What can you expect from this complex surgery?
Picking the Right Team
Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
A Second Opinion Was a Game Changer
Rob Beeler’s treatment for pancreatic cancer took a turn for the better when he went for a second opinion at a major cancer research center.
I Must Give Back
For Joel Evans, it was the unwavering support of his wife Linda that kept him going through a Whipple procedure and chemotherapy.
Don’t Believe the Odds
Anne Seagren is a long-term survivor of pancreatic cancer. Chemotherapy shrank her tumor and made her eligible for a Whipple procedure.
Family History Matters
After Martin Abrams lost two siblings to pancreatic cancer, he made sure he was screened regularly because of his family history.
Quality of Life and Following My Dream
Lee Wonnacott valued his quality of life when he chose treatment for IPMN. Now he rides his motorcycle around the country to honor veterans.
Genomic Testing of Pancreatic Tumor Leads to an Important Discovery
Connie Waxman learned the value of palliative care after chemotherapy, radiation, and a pancreatectomy for pancreatic cancer; then she had genomic testing.
The Bottom Line Is Optimism
For Gary Fong, his optimism about survival is an important part of his treatment along with surgery, chemotherapy, and immunotherapy.
A Routine Physical Saved My Life
John Moisan’s doctor noticed he had lost weight, and insisted he get an abdominal CT scan. They found a pancreatic tumor and he had a pancreatectomy.
My BRCA2 Mutation Turned Out to Be Both the Curse and the Cure
Sharon Seibel knew she had the BRCA2 mutation but was unaware of the link to pancreatic cancer. Her chemotherapy was one for BRCA carriers.
Advances in Pancreatic Neuroendocrine Tumor (PNET) Treatments
Dr. Diane Reidy-Lagunes outlines the current state of treatments for pancreatic neuroendocrine tumors (PNETs).
Why You Need This Simple Blood Test at Diagnosis
An important factor in determining which treatment to use for pancreatic cancer patients is measuring the level of tumor marker CA-19-9. Learn more here.
Choosing the Right Doctor
Rita Krueger made an important decision that changed her pancreatic cancer treatment when she got a second opinion.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
The SHARON Trial
Long-term survivor Sharon Seibel is one of very few to have a clinical trial named for her, thanks to her brother, a cancer researcher.